Hiroko et al. [61] showed that FA can reduce tyrosinase activity by directly binding to enzymes and inhibit the tyrosinase phosphorylation induced by casein kinase 2 (CK2) in B16 melanoma cells in a dose-dependent manner in vitro, thus inhibiting the activation of NF-κB. Here, TYR is linked to melanoma.